Natixis Advisors, L.P.
- SEC CIK
- 0001018331
- Latest filing
- Aug 14, 2026
COLL holding history
Collegium Pharmaceutical, Inc in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
COLL overviewAll 13F holders of COLLFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −24,665−100.0% | Sold out | Holders |
| Q2 2024 | 24,665 | $794.0K | <0.1% | −3,284−11.7% | Reduced | Holders |
| Q1 2024 | 27,949 | $1.08M | <0.1% | +63+0.2% | Added | Holders |
| Q4 2023 | 27,886 | $858.0K | <0.1% | −26,473−48.7% | Reduced | Holders |
| Q3 2023 | 54,359 | $1.22M | <0.1% | +32,865+152.9% | Added | Holders |
| Q2 2023 | 21,494 | $462.0K | <0.1% | +21,494 | New | Holders |